IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.802
EU - Europa 9.753
AS - Asia 9.196
SA - Sud America 2.725
AF - Africa 536
Continente sconosciuto - Info sul continente non disponibili 57
OC - Oceania 11
AN - Antartide 1
Totale 39.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.480
SG - Singapore 2.643
BR - Brasile 2.113
VN - Vietnam 2.113
RU - Federazione Russa 1.689
UA - Ucraina 1.496
IT - Italia 1.386
CN - Cina 1.321
IE - Irlanda 951
HK - Hong Kong 908
DE - Germania 890
SE - Svezia 832
TR - Turchia 760
FI - Finlandia 605
DK - Danimarca 599
FR - Francia 572
KR - Corea 324
GB - Regno Unito 320
IN - India 239
AR - Argentina 228
BD - Bangladesh 213
CI - Costa d'Avorio 180
CA - Canada 151
MA - Marocco 125
MX - Messico 116
NL - Olanda 106
ID - Indonesia 101
EC - Ecuador 90
JP - Giappone 87
IQ - Iraq 86
ZA - Sudafrica 86
CO - Colombia 80
VE - Venezuela 65
PL - Polonia 62
UZ - Uzbekistan 56
EU - Europa 54
ES - Italia 52
CL - Cile 45
PY - Paraguay 45
PK - Pakistan 42
AT - Austria 41
TN - Tunisia 40
PH - Filippine 36
EG - Egitto 29
MY - Malesia 27
SA - Arabia Saudita 27
PE - Perù 26
DZ - Algeria 25
KZ - Kazakistan 25
AE - Emirati Arabi Uniti 24
BE - Belgio 24
JO - Giordania 24
UY - Uruguay 19
LT - Lituania 16
CZ - Repubblica Ceca 15
TH - Thailandia 15
IL - Israele 14
KE - Kenya 13
OM - Oman 13
BO - Bolivia 12
NP - Nepal 12
RS - Serbia 12
AZ - Azerbaigian 11
CR - Costa Rica 11
RO - Romania 11
AL - Albania 10
TW - Taiwan 10
LB - Libano 9
AU - Australia 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
GR - Grecia 8
PS - Palestinian Territory 8
SN - Senegal 8
BG - Bulgaria 7
HU - Ungheria 7
KG - Kirghizistan 7
KW - Kuwait 7
PA - Panama 7
HN - Honduras 6
IR - Iran 6
MN - Mongolia 6
AO - Angola 5
GT - Guatemala 5
SY - Repubblica araba siriana 5
GA - Gabon 4
HR - Croazia 4
JM - Giamaica 4
MD - Moldavia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BZ - Belize 3
GE - Georgia 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
NO - Norvegia 3
PR - Porto Rico 3
Totale 39.032
Salva come PNG Salva come JPEG
Città #
Ashburn 2.444
Jacksonville 1.573
Singapore 1.447
Dallas 1.031
Chandler 1.023
Fairfield 945
Dublin 944
Hong Kong 880
Boardman 851
Ho Chi Minh City 709
San Jose 605
Wilmington 525
Hanoi 473
The Dalles 463
Houston 408
New York 399
Woodbridge 364
Lawrence 358
Princeton 358
Seattle 357
Lauterbourg 345
Des Moines 325
San Mateo 321
Moscow 303
Los Angeles 299
Beijing 270
Cambridge 257
Milan 255
Ann Arbor 252
Helsinki 245
Hefei 229
São Paulo 184
Abidjan 180
Chicago 145
San Diego 139
Munich 126
Da Nang 122
Buffalo 105
Centro 104
Orem 100
Haiphong 90
Council Bluffs 76
Turin 75
Ancona 73
London 72
Redmond 70
Miano 68
Santa Clara 66
Guangzhou 61
Shanghai 60
Rio de Janeiro 58
Tokyo 58
Denver 53
Turku 53
Rome 52
Curitiba 50
Salt Lake City 50
Chennai 48
Warsaw 47
Amsterdam 46
Tashkent 44
Hải Dương 42
Johannesburg 42
Pune 42
Toronto 41
Belo Horizonte 39
Brooklyn 39
Phoenix 39
Frankfurt am Main 38
Montreal 38
Washington 38
Nuremberg 37
Atlanta 36
Biên Hòa 36
Stockholm 36
Thái Bình 36
Brasília 34
San Francisco 34
Boston 33
Columbus 32
Guayaquil 31
Venice 31
Elk Grove Village 29
Manchester 29
Wuhan 29
Campinas 28
Izmir 27
Pianella 27
Poplar 27
Porto 27
Baghdad 25
Mumbai 25
Quito 25
Dhaka 24
Marche 24
Mexico City 24
Philadelphia 24
Thái Nguyên 24
Medellín 23
Fortaleza 21
Totale 22.969
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 381
Specific Anti-Nuclear Antibodies, Clinical Features and Outcome Following Treatment with Nilotinib In Patients with Chronic Graft-Versus-Host Disease. The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Sessions 311
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 310
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 221
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 211
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 202
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 194
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 192
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 189
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 179
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 179
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 176
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 174
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 171
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 171
Glial-like differentiation potential of human mature adipocytes 169
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 167
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 165
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 163
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 162
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 162
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 160
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 159
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 158
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 156
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 156
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 154
[Hodgkin's lymphoma and secondary leukemias]. 154
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 151
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 150
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 150
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 150
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 150
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 150
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 149
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 148
Bone marrow adipocytes support haematopoietic stem cell survival 146
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 145
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 145
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 145
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 145
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 144
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 143
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 143
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 143
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 142
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 142
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 141
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 141
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 141
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 140
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 139
Plasticity of human dedifferentiated adipocytes toward endothelial cells 138
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 138
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 137
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 137
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 137
A rare case of aCML associated with CNS involvement and with aggressive clinical course 137
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 136
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 134
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 133
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 133
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 132
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 132
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 132
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 131
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 130
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 130
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 130
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 129
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 128
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 128
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 127
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 127
[Beta 2-microglobulin in lymphoproliferative disorders]. 126
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 125
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 125
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 125
Molecular and functional characterization of human bone marrow adipocytes 125
History and scientific production of clinica medica and clinica ematologica in ancona 125
[Hairy cell leukemia: therapy with lithium carbonate]. 124
Current Main Topics in Multiple Myeloma 123
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 123
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 123
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 122
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 122
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 122
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 121
A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay 121
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 121
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 120
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 120
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 120
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO) 120
Phototherapy and topical treatments for cutaneous graft vs. host disease in haematopoietic stem cell transplantation patients: a scoping review 120
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 119
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 119
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 118
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 118
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 118
Totale 14.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.951
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 0 179
2021/20222.695 123 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20255.800 644 525 173 61 170 165 753 170 1.205 450 541 943
2025/202616.017 1.004 1.174 1.413 2.113 1.246 1.044 2.647 1.530 1.251 1.263 596 736
Totale 39.651